Brenda Hefti sold $333K of Exelixis (EXEL)

Executed May 18, disclosed May 19, 1 day later.

Value, as filed

$333K

6,625 sh × $50.21

Executed

May 18

the trade date, as filed

Disclosed

May 19

1 day after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

BH Brenda Hefti SVP and General Counsel profile →

Brenda Hefti (SVP and General Counsel) filed 2 Form 4 reports in the trailing twelve months (0 purchases, 2 sales), most often in Exelixis, Inc. (EXEL). The largest single filing was $822K of EXEL (18,669 sh × $44.01, as filed), executed Feb 18.

The name

EXEL Exelixis, Inc. EXEL · Healthcare · 53 filings in 24 months ticker →

Healthcare · Exelixis, Inc., an oncology company, focuses on the discovery, development, and commercialization of new medicines for difficult-to-treat c…

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by Brenda Hefti in EXEL

EXELSALE Exelixis, Inc. $822K
18,669 sh × $44.01
Exec Feb 18
Filed Feb 18 · 5:30 PM ET